Literature DB >> 30607274

Spectrum of Cerebral Venous Thrombosis in Oman.

Darshan Lal1, Arunodaya R Gujjar2, Nandagopal Ramachandiran2, Ammar Obaidi1, Sunil Kumar1, Mortada El-Tigani1, Faizal Al-Azri3, Abdullah R Al-Asmi1.   

Abstract

OBJECTIVES: Cerebral venous thrombosis (CVT) can have varied and life-threatening manifestations. This study aimed to examine the spectrum of its clinical presentations and outcomes in a tertiary hospital in Oman.
METHODS: This retrospective study was conducted at the Sultan Qaboos University Hospital, Muscat, Oman, between January 2009 and December 2017. The medical records of all patients with CVT were reviewed to determine demographic characteristics, clinical features and patient outcomes.
RESULTS: A total of 30 patients had CVT. The mean age was 36.8 ± 11 years and the male-to-female ratio was 2:3. Common manifestations included headache (83%), altered sensorium (50%), seizures (43%) and hemiparesis (33%). Underlying risk factors were present in 16 patients (53%). Computed tomography or magnetic resonance imaging of the brain was abnormal in all patients, with indications of infarcts (40%) and major sinus thrombosis (100%). There were five cases (20%) of deep CVT. The patients were treated with low-molecular-weight heparin, mannitol and anticonvulsants. The majority (77%) had no residual neurological deficits at follow-up.
CONCLUSION: These findings indicate that CVT is a relatively uncommon yet treatable disorder in Oman. A high index of suspicion, early diagnosis, prompt anticoagulation treatment and critical care may enhance favourable patient outcomes.

Entities:  

Keywords:  Cerebral Thrombosis; Cranial Venous Sinuses; Neurological Manifestations; Oman; Patient Outcome Assessment; Venous Thrombosis

Mesh:

Year:  2018        PMID: 30607274      PMCID: PMC6307648          DOI: 10.18295/squmj.2018.18.03.011

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  25 in total

Review 1.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

2.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis.

Authors:  K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

Review 3.  Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Gustavo Saposnik; Fernando Barinagarrementeria; Robert D Brown; Cheryl D Bushnell; Brett Cucchiara; Mary Cushman; Gabrielle deVeber; Jose M Ferro; Fong Y Tsai
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

4.  Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam's Institute Venous Stroke Registry, Hyderabad (India).

Authors:  Deekshanti Narayan; Subhash Kaul; K Ravishankar; T Suryaprabha; V C S Srinivasarao Bandaru; K Rukmini Mridula; S A Jabeen; Suvarna Alladi; A K Meena; Rupam Borgohain
Journal:  Neurol India       Date:  2012 Mar-Apr       Impact factor: 2.117

5.  Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.

Authors:  Jonathan M Coutinho; José M Ferro; Susanna M Zuurbier; Marieke S Mink; Patrícia Canhão; Isabelle Crassard; Charles B Majoie; Jim A Reekers; Emmanuel Houdart; Rob J de Haan; Marie-Germaine Bousser; Jan Stam
Journal:  Int J Stroke       Date:  2012-02-20       Impact factor: 5.266

Review 6.  Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls.

Authors:  James L Leach; Robert B Fortuna; Blaise V Jones; Mary F Gaskill-Shipley
Journal:  Radiographics       Date:  2006-10       Impact factor: 5.333

Review 7.  Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data.

Authors:  José M Ferro; Isabelle Crassard; Jonathan M Coutinho; Patrícia Canhão; Fernando Barinagarrementeria; Brett Cucchiara; Laurent Derex; Christoph Lichy; Jaime Masjuan; Ayrton Massaro; Gonzalo Matamala; Sven Poli; Mohammad Saadatnia; Erwin Stolz; Miguel Viana-Baptista; Jan Stam; Marie-Germaine Bousser
Journal:  Stroke       Date:  2011-07-28       Impact factor: 7.914

8.  Significance of seizure in cerebral venous sinus thrombosis.

Authors:  Jayantee Kalita; Satish Chandra; Usha Kant Misra
Journal:  Seizure       Date:  2012-07-26       Impact factor: 3.184

9.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

10.  Acute treatment of cerebral venous and dural sinus thrombosis.

Authors:  José M Ferro; Patrícia Canhão
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

View more
  1 in total

1.  Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis.

Authors:  Khalid Al Hashmi; Kamla Al Wahaibi; Murtadha Al-Khabori; Sulayma Al Lamki
Journal:  Oman Med J       Date:  2019-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.